EP3812365 - ROSMARINIC ACID DERIVATIVE OR SALT THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 26.03.2021 Database last updated on 03.09.2024 | |
Former | The international publication has been made Status updated on 27.12.2019 | Most recent event Tooltip | 24.06.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Kao Corporation 14-10, Nihonbashi-Kayabacho 1-chome Chuo-ku Tokyo 103-8210 / JP | [2021/17] | Inventor(s) | 01 /
TAKAMURA, Akihiro c/o Kao Corporation Research Laboratories, 2606 Akabane, Ichikai-machi Haga-gun, Tochigi 321-3497 / JP | 02 /
KITAMURA, Naoya c/o Kao Corporation Research Laboratories, 2606 Akabane, Ichikai-machi Haga-gun, Tochigi 321-3497 / JP | 03 /
YAMAMOTO, Naoki c/o Kao Corporation Research Laboratories, 2606 Akabane, Ichikai-machi Haga-gun, Tochigi 321-3497 / JP | 04 /
HASHIZUME, Kohjiro c/o Kao Corporation Research Laboratories, 2606 Akabane, Ichikai-machi Haga-gun, Tochigi 321-3497 / JP | [2021/17] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [2021/17] | Application number, filing date | 19821672.3 | 19.06.2019 | [2021/17] | WO2019JP24322 | Priority number, date | JP20180117368 | 20.06.2018 Original published format: JP 2018117368 | [2021/17] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019244937 | Date: | 26.12.2019 | Language: | JA | [2019/52] | Type: | A1 Application with search report | No.: | EP3812365 | Date: | 28.04.2021 | Language: | EN | [2021/17] | Search report(s) | International search report - published on: | JP | 26.12.2019 | (Supplementary) European search report - dispatched on: | EP | 18.02.2022 | Classification | IPC: | C07C69/732, A23L33/10, A61K31/216, A61P1/12, A61P13/10, A61P43/00, C07C69/736, C07K14/47 | [2021/17] | CPC: |
A23L33/105 (EP,US);
C07C69/736 (US);
A61K31/216 (EP);
A61P1/12 (EP);
A61P13/10 (EP);
C07C69/732 (EP);
C07C69/734 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/17] | Title | German: | ROSMARINSÄUREDERIVAT ODER SALZ DAVON | [2021/17] | English: | ROSMARINIC ACID DERIVATIVE OR SALT THEREOF | [2021/17] | French: | DÉRIVÉ D'ACIDE ROSMARINIQUE OU SEL DE CELUI-CI | [2021/17] | Entry into regional phase | 19.01.2021 | Translation filed | 19.01.2021 | National basic fee paid | 19.01.2021 | Search fee paid | 19.01.2021 | Designation fee(s) paid | 19.01.2021 | Examination fee paid | Examination procedure | 19.01.2021 | Examination requested [2021/17] | 23.06.2022 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 25.06.2021 | Renewal fee patent year 03 | 31.03.2022 | Renewal fee patent year 04 | 31.03.2023 | Renewal fee patent year 05 | 24.06.2024 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO0156555 (GLAXO GROUP LTD [GB], et al) [Y] 4,7,10,13 * claims 1-3 *; | [Y]WO03070233 (PHARMACIA CORP [US], et al) [Y] 3,6,9,12 * the whole document *; | [XY]JP2005272362 (MEIJI SEIKA KAISHA) [X] 1-8,14-16 * paragraphs [0006] , [0007] , [0021] , [0022]; claims 1-8 * [Y] 3,4,6,7,9,10,12,13; | [I]US2008031980 (RODRIGUEZ AL [US], et al) [I] 3,6,9,12 * paragraphs [0001] , [0011] , [0012] , [0033]; claims 1,2,18 *; | [XI]WO2016122889 (KALEIDO BIOSCIENCES INC [US]) [X] 1-4,8 * page 199; claim 65; table 5 * * pages 75-76 * [I] 5-7; | [I]JP2017052747 (KAO CORP) [I] 3,6,9,12 * paragraphs [0018] , [0044] , [0045]; claims 1,2 *; | [XP]JP2018177738 (KAO CORP) [XP] 1-16 * the whole document *; | [XP]JP2018177739 (KAO CORP) [XP] 1-16* paragraphs [0005] , [0011] , [0015] , [0017] , [0030] , [0031] , [0053] , [0055]; claims 2-6 *; | [E]JP2020033272 (KAO CORP) [E] 1,3 * claims 1,2,4-7 *; | [E]WO2020075764 (KAO CORP [JP]) [E] 1-16 * pages 11-12, paragraph 39 - page 14, paragraph 47; claims 1-3,5,7,8 * * page 11, paragraph 38 - page 14, paragraph 46 *; | [XI] - AL-QUDAH MAHMOUD A. ET AL, "Flavonoid and phenolic compounds from Salvia palaestina L. growing wild in Jordan and their antioxidant activities", PHYTOCHEMISTRY, Amsterdam , NL, vol. 99, doi:10.1016/j.phytochem.2014.01.001, ISSN 0031-9422, (20140301), pages 115 - 120, URL: https://www.sciencedirect.com/science/article/pii/S0031942214000041/pdfft?md5=95c8890eca0a0d5ecbcb76e76a280d49&pid=1-s2.0-S0031942214000041-main.pdf, XP055888888 [X] 1-4 * page 116, column l, paragraph 2; figure 1; compounds 3,7 * [I] 5-7 DOI: http://dx.doi.org/10.1016/j.phytochem.2014.01.001 | [X] - ZENG BIAO ET AL, "and Their Inhibitory Effects on [alpha] -Glucosidase and Vascular Endothelial Cells Injury", CHEMISTRY & BIODIVERSITY, CH, (20160501), vol. 13, no. 5, doi:10.1002/cbdv.201500187, ISSN 1612-1872, pages 596 - 601, XP055888867 [X] 1-4 * abstract * DOI: http://dx.doi.org/10.1002/cbdv.201500187 | [I] - ALLAM SHADY ET AL, "Extracts from peppermint leaves, lemon balm leaves and in particular angelica roots mimic the pro-secretory action of the herbal preparation STW 5 in the human intestine", PHYTOMEDICINE, AMSTERDAM, NL, (20151101), vol. 22, no. 12, doi:10.1016/j.phymed.2015.08.008, ISSN 0944-7113, pages 1063 - 1070, XP055889298 [I] 4,7,10,13 * abstract * * pages 1065,-69 * * page 1070, column l, paragraph 3 * DOI: http://dx.doi.org/10.1016/j.phymed.2015.08.008 | [I] - MCKAY ET AL, "A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.)", PHYSIOTHERAPY RESEARCH, JOHN WILEY & SONS LTD. CHICHESTER, GB, (20060801), vol. 20, no. 8, doi:10.1002/PTR.1936, ISSN 0951-418X, pages 619 - 633, XP009145205 [I] 4,7,10,13 * the whole document * DOI: http://dx.doi.org/10.1002/ptr.1936 | International search | [A]JP2000072685 (NAGASE & CO LTD) [A] 1-22 * , *; | [A]WO02062365 (MEIJI SEIKA KAISHA [JP], et al) [A] 1-22 * , *; | [YA]JP2003521511 [Y] 4, 7, 10, 13, 19 , 22 * , * [A] 1-3, 5, 6, 8, 9, 11, 12, 14-18, 20, 21; | [YA]JP2005526040 [Y] 3, 6, 9, 12, 18, 21 * , * [A] 1, 2, 4, 5, 7, 8, 10, 11, 13-17, 19, 20, 22; | [XYA]JP2005272362 (MEIJI SEIKA KAISHA) [X] 1, 14-16 * , * [Y] 3, 4, 6, 7, 9, 10 , 12, 13, 18, 19 , 21, 22 [A] 2, 5, 8, 11, 17, 20; | [A]JP2013216592 (KAO CORP) [A] 1-22* , * | by applicant | JP2005139136 | KR20130087877 | JP2014024809 | - TIAN W., Am. J. Physiol. Renal. Physiol., (20040000), vol. 287, pages F17 - F24 | - NILIUS B., Physiol. Rev., (20070000), vol. 87, pages 165 - 217 | - GEVAERT T., J. Clin. Invest., (20070000), vol. 117, pages 3453 - 3462 | - NICOLAS CENAC et al., Gastroenterology, (20150000), vol. 149, pages 433 - 444 |